Tyra Biosciences, Inc. (TYRA)
35.04
+0.50
(+1.45%)
USD |
NASDAQ |
Mar 06, 16:00
35.07
+0.03
(+0.09%)
After-Hours: 20:00
Tyra Biosciences Cash from Investing (TTM) : 72.46M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Spyre Therapeutics, Inc. | -143.48M |
| Agios Pharmaceuticals, Inc. | 377.18M |
| BridgeBio Pharma, Inc. | -22.34M |
| Nuvalent, Inc. | -124.08M |
| ACADIA Pharmaceuticals, Inc. | -302.56M |